Retrieve available abstracts of 6 articles: HTML format
Single Articles
August 2025
GANJGAHI H, Haring DA, Aarden P, Graham G, et al AI-driven reclassification of multiple sclerosis progression.
Nat Med. 2025 Aug 20. doi: 10.1038/s41591-025-03901. PubMedAbstract available
April 2025
KLOTZ L, Smolders J, Lehto J, Matilainen M, et al Broad rim lesions are a new pathological and imaging biomarker for rapid disease
progression in multiple sclerosis.
Nat Med. 2025 Apr 29. doi: 10.1038/s41591-025-03625. PubMedAbstract available
July 2024
MEI F, Fancy SPJ, Shen YA, Niu J, et al Author Correction: Micropillar arrays as a high-throughput screening platform for
therapeutics in multiple sclerosis.
Nat Med. 2024 Jul 12. doi: 10.1038/s41591-024-03162. PubMed
April 2024
ZAMECNIK CR, Sowa GM, Abdelhak A, Dandekar R, et al An autoantibody signature predictive for multiple sclerosis.
Nat Med. 2024 Apr 19. doi: 10.1038/s41591-024-02938. PubMedAbstract available
ARNOLD C 'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to
celiac disease.
Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024. PubMed
July 2023
CARVALHO T Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis.
Nat Med. 2023 Jul 5. doi: 10.1038/d41591-023-00060. PubMed